Skip to content
2000
Volume 21, Issue 3
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Background

Oral or cervical cancer is caused by the abnormal growth of cells, which in 90% of cases is caused by the human papillomavirus infection.

Objective

The present study aimed to determine the prevalence of cervical cancer and premalignant cases based on the results of Pap smears performed in Jiroft health centers in 2022.

Methods

This cross-sectional study was conducted on 440 women using a census method, and the demographic information of the people and the results of their Pap smears were recorded using a researcher-made questionnaire.

Results

The average age of the investigated women was 37.20 ± 9.09 years, with the highest frequency in the age group of 30 to 40 years (44.7%), and the average number of previous pregnancies was 3.06 ± 2.26 times, with the highest frequency observed in the group 1 to 2 times (50.6%). The average number of abortions was 0.45 ± 0.86, with the highest frequency (70.4%) related to the group that had no history of abortion. Out of 440 people examined, 6 (1.4%) with a 95% confidence interval equal to 0.50-2.94% had abnormal Pap smears.

Conclusion

The number of pregnancies and the increase in the number of abortions can be factors influencing the incidence of cervical cancer. By performing a Pap smear screening test with early diagnosis of the disease in the early stages, it is possible to prevent the spread of this disease in the body and the transformation of these cells into cancer.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cctr/10.2174/0115733947295059240326055329
2024-04-05
2025-09-05

  • From This Site

    /content/journals/cctr/10.2174/0115733947295059240326055329
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. HackerN. Cervical cancer. In: Berek J, Hacker N, Eds. Practical Gynecologic Oncology.4th ed BerekJ. HackerN. PhiladelphiaLippincott Williams & Wilkins2005337386
     [Google Scholar]
  2. BralyP. SedlacekT. KinneyW. Reporting the potential benefits of new technologies for cervical cancer screening.J. Low. Genit. Tract Dis.2001527381 17043579
     [Google Scholar]
  3. LiuS. SemenciwR. ProbertA. MaoY. Cervical cancer in Canada: Changing patterns in incidence and mortality.Int. J. Gynecol. Cancer2001111243110.1046/j.1525‑1438.2001.011001024.x 11285030
     [Google Scholar]
  4. ErcoliA. IannoneV. LeggeF. Advances in surgical management of cervical cancer.Minerva Ginecol.2009613227237 19415066
     [Google Scholar]
  5. CollymoreY. Removing Barriers to Early Detection Key to Cervical Cancer Prevention.Population Reference Bureau Available From2008
     [Google Scholar]
  6. ElizabetJ. EdwardE. PartridgeM. AlanJ. Mayerd. The impact of eliminating socioeconomic and racial disparities on premature cancer death. cancer statistics.CA Cancer J. Clin.2011614205282 21685463
     [Google Scholar]
  7. JemalA. BrayF. CenterM.M. FerlayJ. WardE. FormanD. Global cancer statistics.CA Cancer J. Clin.2011612699010.3322/caac.20107 21296855
     [Google Scholar]
  8. ForouzanfarM.H. ForemanK.J. DelossantosA.M. Breast and cervical cancer in 187 countries between 1980 and 2010: A systematic analysis.Lancet201137898011461148410.1016/S0140‑6736(11)61351‑2 21924486
     [Google Scholar]
  9. FoleyG. AlstonR. GeraciM. BrabinL. KitchenerH. BirchJ. Increasing rates of cervical cancer in young women in England: An analysis of national data 1982–2006.Br. J. Cancer2011105117718410.1038/bjc.2011.196 21654675
     [Google Scholar]
  10. ArbynM. AntoineJ. MägiM. Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.Int. J. Cancer201112881899190710.1002/ijc.25525 20568103
     [Google Scholar]
  11. FerlayJ. ShinH.R. BrayF. FormanD. MathersC. ParkinD.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.Int. J. Cancer2010127122893291710.1002/ijc.25516 21351269
     [Google Scholar]
  12. PatraS. PandaD. Cervical cancer screening in developing countries.Indian J. Cancer201047334434510.4103/0019‑509X.64704 20587915
     [Google Scholar]
  13. PandhiD. SonthaliaS. Human papilloma virus vaccines: Current scenario.Indian J. Sex. Transm. Dis.2011322758510.4103/0253‑7184.85409 22021967
     [Google Scholar]
  14. ThomasB. RobertaM. The world health organization collabrative study of neoplasia and steroid contraception. Oral contraceptive and invasive adenocarcinoma and adenosquamous carcinoma of the cervix.Am. J. Epidemiol.1996144328110.1093/oxfordjournals.aje.a008923 8686697
     [Google Scholar]
  15. VesseyM.P. LawlessM. McphersonK. YeatesD. Oral contraceptives and cervical cancer.Lancet198332283631358135910.1016/S0140‑6736(83)91108‑X 6139685
     [Google Scholar]
  16. LouieK.S. de SanjoseS. DiazM. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries.Br. J. Cancer200910071191119710.1038/sj.bjc.6604974 19277042
     [Google Scholar]
  17. Berrington de GonzálezA. SweetlandS. GreenJ. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: A meta-analysis.Br. J. Cancer.2004 May 49091787179110.1038/sj.bjc.660176415150591
     [Google Scholar]
  18. OncinsR. FuenteC. NajarM. Descriptive study of cervical intraepithecal neoplasia grade III cases in the area of the hospital of barbastro.Aten. Primaria2001287457462 11718640
     [Google Scholar]
  19. MohagheghF. AhmadlouM. A study of the prevalence of cervical cancer among married wemon in Arak, 2013.J. Arak Univ. Med. Sci.20151846570
     [Google Scholar]
  20. IlanaB. KennethD. HatchJ. Intraepithelial disease of the cervix, vagina and vulva. In: Berek JS, Ed. Novak’s Gynecology. BerekJ.S. Lippincott Williams and Wilkins2007561585
     [Google Scholar]
  21. MasoumiS.Z. KhaniS. GharosianM. FarhadianM. ShayanA. The prevalence of abnormal pap smears in females referred to health centers affiliated to medical sciences during the years 2012 to 2016.J Educ Community Health201732162210.21859/jech‑03023
     [Google Scholar]
  22. EhdaeevandF. NeeknejadM. AminisaniN. ChinifroushM. ChinifroushM. Cervix dysplasia in 5000 pap smears in ardabil.J Ardabil Univ Med Sci2005512225
     [Google Scholar]
  23. YangR.C. MillsP.K. DodgeJ.L. Cancer screening, reproductive history, socioeconomic status, and anticipated cancer-related behavior among Hmong adults.Asian Pac. J. Cancer Prev.2006717985 16629521
     [Google Scholar]
  24. KrivakT.H.C. MacbroomJ.W. ElkasJ.C. Cervical and vaginal cancer. In: Novak’s Gynecology.13th edPhiladelphiaWilliams and Wilkins200211991232
     [Google Scholar]
  25. MaoC. BalasubramanianA. KoutskyL.A. Should liquid-based cytology be repeated at the time of colposcopy?Obstet. Gynecol. Surv.200560743743810.1097/01.ogx.0000168541.95262.f9
     [Google Scholar]
  26. Almassi NokianiF. AkbariH. Prevalence of invasive and pre- invasive cervical lesions in kermanshah (2003-2007).J. Inflamm.2015181020
     [Google Scholar]
  27. MehdizadehA. AkbarianA. MaghazeiT. Evaluation for 3000 specimens of pap smears in the married women inhabitant of south of Tehran during the years 1376 and 1377.Feyz1999333237
     [Google Scholar]
  28. JafariM. HalimiM. Dastranj TabriziA. Prevalence of for precancerous and invasive cancer lesions of cervix tabriz. J Women.Midwifery Infertility20161026378
     [Google Scholar]
  29. ThistleP.J. ChirenjeZ.M. Cervical cancer screening in a rural population of Zimbabwe.Cent. Afr. J. Med.1997439246251 9509642
     [Google Scholar]
  30. ZamaniM. TorabianS. Evaluation the colposcopic and histologic findings in oncology ward of fatemieh hospital, Hamadan, Iran.Iranian J Obstetr201316781610.22038/ijogi.2013.2146
     [Google Scholar]
  31. McCrory DC, Matchar DB, Bastian L, Datta S, Hasselblad V, Hickey J, Myers E, Nanda K. Evaluation of cervical cytology.Evid Rep Technol Assess (Summ)199951611925972PMC4781480
     [Google Scholar]
  32. MehrafzaM. Amadeh-ZiabariM. A comparative study on colposcopy and cervical biopsy findings in patients with minimally abnormal pap smear test.Majallah-i Danishgah-i Ulum-i Pizishki-i Gilan200312466268
     [Google Scholar]
  33. FakorF. Aghaee NejadS. MoosaviS. Pathologic findings of endocervical curettage in routine colposcopy in abnormal pap smear.Majallah-i Danishgah-i Ulum-i Pizishki-i Gilan2013228716
     [Google Scholar]
  34. Cervical cancer preventation: Cost–effective screeningFrom meadscape general medicine.Available At: https:Www.MedScape.Com/Viewarticle/408875+2 Accessed In: 2005/Jun/07.2005
  35. SasieniP. CastanonA. Call and recall cervical screening programme: Screening interval and age limits.Curr. Diagn. Pathol.200612211412610.1016/j.cdip.2005.12.006
     [Google Scholar]
  36. SubaE.J. HungN.C. DucN.B. RaabS.S. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.Cancer200191592893910.1002/1097‑0142(20010301)91:5<928::AID‑CNCR1082>3.0.CO;2‑S 11251944
     [Google Scholar]
  37. EddyD.M. Screening for cervical cancer.Ann. Intern. Med.1990113321422610.7326/0003‑4819‑113‑3‑214 2115753
     [Google Scholar]
  38. GoldieS.J. GaffikinL. Goldhaber-FiebertJ.D. Cost-effectiveness of cervical-cancer screening in five developing countries.N. Engl. J. Med.2005353202158216810.1056/NEJMsa044278 16291985
     [Google Scholar]
  39. BrockK.E. BerryG. KerrC. Sexual, reproductive and contraceptive risk factors for carcinoma‐in‐situ of the uterine cervix in Sydney.Med. J. Aust.1989150312513010.5694/j.1326‑5377.1989.tb136389.x 2716580
     [Google Scholar]
  40. PatroB.K. NongkynrihB. Review of screening and preventive strategies for cervical cancer in India.Indian J. Public Health2007514216221 18232160
     [Google Scholar]
  41. NojomiM. ModaresM. ErfaniA. The study of frequency of risk factors of cervical cancer among women attending general hospitals in Tehran.J Iran Univ Med Sci2016110
     [Google Scholar]
  42. MuñozN. FranceschiS. BosettiC. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.Lancet200235993121093110110.1016/S0140‑6736(02)08151‑5 11943256
     [Google Scholar]
  43. HinkulaM. PukkalaE. KyyrönenP. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland.Br. J. Cancer20049051025102910.1038/sj.bjc.6601650 14997202
     [Google Scholar]
  44. HarahapR.E. Influence of sexual activity on development of cervical intraepithelial neoplasia (CIN).Cancer Detect. Prev.198693-4237241 3742503
     [Google Scholar]
  45. ReisF.M. OliveiraL.L. de Fátima BritoM. The association of age and sexual history with the severity of the histological findings in women with cervical intraepithelial neoplasia.Gynecol. Obstet. Invest.199642425826010.1159/000291976 8979099
     [Google Scholar]
/content/journals/cctr/10.2174/0115733947295059240326055329
Loading
Prevalence of Cervical Cancer and Premalignant Cases Based on Pap Smear Screening in Iran in 2022
Curr Cancer Ther Rev 21, 420 (2025); https://doi.org/10.2174/0115733947295059240326055329
/content/journals/cctr/10.2174/0115733947295059240326055329
/content/journals/cctr/10.2174/0115733947295059240326055329
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): abortion; cancer; cervical; cervical cancer; Pap smear; pregnancy; premalignant; Prevalence; screening

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test